<DOC>
	<DOCNO>NCT02187757</DOCNO>
	<brief_summary>Study evaluate Efficacy Safety PreLipid® subject high normal blood lipid level</brief_summary>
	<brief_title>Study Evaluate Efficacy Safety PreLipid® Subjects With Higher Than Normal Blood Lipid Levels</brief_title>
	<detailed_description>A Prospective , Double Blind , Placebo-Controlled , Randomized , Multicentric , study evaluate safety , efficacy tolerability PreLipid® , twice-daily nutritional supplement subject high normal blood lipid level</detailed_description>
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>Newly diagnose Male Female participants high normal cholesterol level define American Heart Association , National Cholesterol Education Program ( NCEP ) ATPIII goal LDL cholesterol cut point therapeutic lifestyle change ( TLCs ) drug therapy different risk category : 1 . Age ≥ 18 year ≤ 65 year 2 . LDL cholesterol level &gt; 120mg/dl 3 . Ability understand willingness sign date write Informed Consent Document screen visit protocol specific procedure perform willing adhere protocol entire trial procedure 1 . Stroke , myocardial infarction , coronary artery bypass graft ( CABG ) percutaneous transluminal coronary angioplasty ( PTCA ) angina pectoris past . 2 . Cardiac status New York Heart Association class IIIIV 3 . Uncotrolled blood pressure &gt; 150 mmhg systolic &gt; 100 mmhg diastolic 4 . Impaired renal function show limited serum creatinine ≥ 1.5 mg/dl male ≥ 1.4 mg/dl female 5 . Clinically significant peripheral edema 6 . Clinical evidence active liver disease serum alenine aminotransferase ( ALT ) aspartate amino transferase ( AST ) 2.5 time upper limit normal range ( 2.5 X ULN ) 7 . Participants steroid 8 . Pregnancy lactate woman 9 . Known hypersensitivity study drug 10 . Any malignancy within last 5 year , exception adequately treat basal squamous cell carcinoma skin adequately treat carcinoma insitu . 11 . Current addiction current alcohol abuse history substance alcohol abuse within last 2 year 12 . Subject investigator subinvestigator , research assistant , pharmacist , study coordinator , staff relative thereof directly involve conduct protocol 13 . Mental condition render subject unable understand nature , scope possible consequence study . 14 . Subject unlikely comply protocol e.g . uncooperative attitude , inability return follow visit unlikelihood complete study 15 . Any disease condition opinion investigator and/or sponsor may interfere completion studyevaluation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Dyslipidemia</keyword>
	<keyword>High cholesterol</keyword>
	<keyword>High LDL</keyword>
	<keyword>Triglycerides</keyword>
</DOC>